NCT00215124View on ClinicalTrials.gov

A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction

PHASE1/PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

February 28, 2007

Conditions

Acute Myocardial Infarction

Interventions

DRUG

Filgrastim

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER